Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)
China flag China · Delayed Price · Currency is CNY
11.99
+0.03 (0.25%)
Jul 29, 2026, 3:00 PM CST

Jiangsu Yahong Meditech Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
287.11277.12201.5613.750.030
Revenue Growth
20.46%37.49%1365.55%52604.89%470.51%-
Gross Profit
208.54205.15151.2510.83-1.81-1.19
Operating Income
-470.48-445.66-426.38-471.47-334.27-255.82
Net Income
-445.25-416.38-384.06-400.43-246.55-234.95
Earnings Per Share
-0.79-0.74-0.68-0.70-0.43-0.51
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,3831,6091,4362,3472,7382,983
Total Debt
357.29345.15130.54134.4618.6917.42
Net Cash (Debt)
1,0251,2641,3052,2132,7202,966
Net Cash Growth
-31.57%-3.21%-41.00%-18.64%-8.29%271.31%
Net Cash Per Share
1.822.252.313.704.746.44

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-425.94-411.79-424.95-398.19-241.96-171.52
Capital Expenditures
-22.62-19.12-5.79-101.63-26.61-42.4
Free Cash Flow
-448.56-430.92-430.74-499.82-268.57-213.92
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
72.64%74.03%75.04%78.72%--
Operating Margin
-163.87%-160.82%-211.54%-3428.02%-1280959.60%-5592976.39%
Pretax Margin
-160.71%-156.40%-191.90%-2919.31%-939900.69%-5132362.79%
Profit Margin
-155.08%-150.25%-190.54%-2911.54%-944816.18%-5136625.82%
FCF Margin
-156.24%-155.50%-213.70%-3634.18%-1029206.22%-4676788.98%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
23.4923.3618.92446.77245736.73-